Control of systemic B cell-mediated autoimmune disease by nonmyeloablative conditioning and major histocompatibility complex-mismatched allogeneic bone marrow transplantation.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Blood

• Publication date

  2005-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD-2004-09-3715PMID 15604221
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism.

  2004cited by this paper
• Mixed hematopoietic chimerism allows cure of autoimmune diabetes through allogeneic tolerance and reversal of autoimmunity.

  2004cited by this paper
• Mechanisms of early peripheral CD4 T-cell tolerance induction by anti-CD154 monoclonal antibody and allogeneic bone marrow transplantation: evidence for anergy and deletion but not regulatory cells.

  2004cited by this paper
• Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockade

  2003cited by this paper
• CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis.

  2003cited by this paper
• Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure?

  2002cited by this paper
• An animal model for human cellular immunotherapy: specific eradication of human acute lymphoblastic leukemia by cytotoxic T lymphocytes in NOD/scid mice.

  2002cited by this paper
• Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: Getting closer to a cure?

  2002cited by this paper
• CD4 T Cell-Mediated Alloresistance to Fully MHC-Mismatched Allogeneic Bone Marrow Engraftment Is Dependent on CD40-CD40 Ligand Interactions, and Lasting T Cell Tolerance Is Induced by Bone Marrow Transplantation with Initial Blockade of this Pathway1

  2001cited by this paper
• Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment

  2000cited by this paper
• The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation.

  2000cited by this paper
• Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect.

  2000cited by this paper
• Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.

  1999cited by this paper
• Long‐term outcome of autoimmune disease following allogeneic bone marrow transplantation

  1998cited by this paper
• Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation.

  1998cited by this paper
• Outcome of rheumatoid arthritis and psoriasis following autologous stem cell transplantation for hematologic malignancy.

  1997cited by this paper
• Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice.

  1996cited by this paper
• Apparent cure of rheumatoid arthritis by bone marrow transplantation.

  1993cited by this paper
• Resolution of immune-mediated diseases following allogeneic bone marrow transplantation for leukaemia.

  1992cited by this paper
• The half‐lives of serum immunoglobulins in adult mice

  1988cited by this paper
• Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow transplantation for drug-induced aplastic anaemia.

  1986cited by this paper

• Leveraging the lymphohematopoietic graft-versus-host reaction (LGVHR) to achieve allograft tolerance and restore self tolerance with minimal toxicity

  2023cites this paper
• The Experimental Basis for Hematopoietic Cell Transplantation for Autoimmune Diseases

  2016cites this paper
• Dexamethasone Preconditioning Improves the Response of Collagen-Induced Arthritis to Treatment with Short-Term Lipopolysaccharide-Stimulated Collagen-Loaded Dendritic Cells

  2013cites this paper
• Mesenchymal stem cells in autoimmune diseases: hype or hope?

  2010cites this paper
• Stem cells in the treatment of inflammatory arthritis.

  2010cites this paper
• Stem cell transplantation for rheumatic autoimmune diseases

  2008cites this paper
• The regulation of autoreactive B cells during innate immune responses

  2008cites this paper
• Treatment with anti‐TNFα does not induce reactivation of latent Salmonella enterica serovar Typhimurium infection in C3H/HeN mice

  2007cites this paper
• Targeting host B-cell immune responses by persistent donor NK-cell alloreactivity following nonmyeloablative allogeneic stem cell transplantation.

  2007cites this paper
• Effect of the new HJV-L165X mutation on penetrance of HFE.

  2007cites this paper
• Cell therapy for autoimmune diseases

  2007cites this paper
• Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases.

  2005cites this paper